Great Lakes and Mid-Atlantic clinical trials hub for substance use treatment
Great Lakes & Mid-Atlantic Node (GLMN) of the NIDA CTN
This program connects people with substance use disorders in the Midwest and Mid-Atlantic to clinical trials testing more personalized treatment approaches.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11261197 on NIH RePORTER |
What this research studies
You would access a regional hub that runs and supports clinical trials for people with substance use disorders across the Midwest and Mid-Atlantic. The hub brings together investigators from the University of Illinois at Chicago, Howard University, RTI International, and other partners to design trials using precision medicine approaches. They will help recruit and keep diverse participants, collect clinical and biological samples, and offer opportunities to join intervention or treatment studies. The node also trains researchers and shares resources with other CTN sites to broaden trial availability.
Who could benefit from this research
Good fit: Adults and adolescents with substance use disorders who live in or can travel to the Chicago/Midwest or Mid-Atlantic regions and who are willing to enroll in clinical trials or provide health information/samples are ideal candidates.
Not a fit: People without substance use disorders, those outside the service regions, or those unwilling or unable to join trials are unlikely to receive direct benefit from this node.
Why it matters
Potential benefit: If successful, the network could increase access to tailored treatment trials and make it easier for patients to join research that matches their needs.
How similar studies have performed: The NIDA Clinical Trials Network has successfully run many multisite addiction treatment trials, though applying precision medicine methods to substance use is a newer approach.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Karnik, Niranjan Subhash — University of Illinois at Chicago
- Study coordinator: Karnik, Niranjan Subhash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.